PENTAFERTE ITALIA

What PENTAFERTE ITALIA does

Pentaferte Italia S.r.l. Unipersonale is a privately held Italian medical device manufacturer founded in 1980 and headquartered at its production site in Campli (province of Teramo, approximately two hours from Rome). The company specializes in the design and manufacturing of syringes and hypodermic needles, operating one of the largest syringe production facilities in Europe, spanning over 20,000 m² and running three-shift, 24-hour production. Its product portfolio includes three-piece syringes with and without needles (0.5 ml to 100 ml, transparent and amber light-resistant variants, Luer Lock and Luer Slip configurations), PentaFlush sterile pre-filled saline syringes (3/5/10/20 ml) for vascular access flushing, large capacity syringes (50/60/100 ml), PentaLance silicone-coated triple-sharpened hypodermic needles, PentaFine R0 zero-residue syringes for diabetic patients, blood lancets, and OEM custom manufacturing services. Manufacturing follows a vertically integrated process comprising in-house injection moulding, clean room assembly, silicone coating, heat-sealed blister packaging, and ethylene oxide sterilization validated under ISO 11135:2014. The company is certified to ISO 13485:2016 and holds EU MDR 2017/745 conformity (certificate Pentaferte-Italia-0048).

The company's revenue model is direct B2B hardware sales of medical devices, with quote-based pricing negotiated against multi-year contracts and no public pricing. Customers span four segments: hospitals and healthcare facilities (primary), the pharmaceutical industry (primary), home care providers, and veterinary clinics. Distribution is executed through direct enterprise sales, a wholly-owned French subsidiary (Pentaferte France, Villeparisis, led by Xavier Mesnil), and an active presence at major international trade fairs (Arab Health Dubai, WoCoVA Prague, FIME Miami, COMPAMED/MEDICA Düsseldorf). Pentaferte is a participant of the United Nations Global Compact. Since October 2022, Pentaferte has operated as a wholly-owned subsidiary of Delta Med Spa, controlled by private equity sponsor White Bridge Investments, and in November 2023 became part of the unified Numantec Group (New Human Innovation Technology), which combines Delta Med, Pentaferte, DBM, AdriaMed, BEL, Securmed, PHS Medical, and Health Line, reporting over EUR 100 million in turnover, 6 production plants in Italy and France, and over 400 employees. Gianluca Romagnoli, of the founding Romagnoli family, continues in a senior leadership role.

Name

PENTAFERTE ITALIA

Legal name

Pentaferte Italia S.r.l. Unipersonale

Website

https://pentaferte.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Pentaferte Italia is a privately held Italian medical device manufacturer founded in 1980, producing syringes, hypodermic needles, blood lancets, and pre-filled saline syringes at one of Europe's largest syringe facilities in Campli. The company serves hospitals, pharmaceutical companies, home care providers, and veterinary clinics globally as part of the Numantec Group.

Ownership category

akta.pro rank

Product category

Medical Device Manufacturing

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Medical Equipment and Supplies Manufacturing (33911)

SIC

Surgical & Medical Instruments & Apparatus (3841), Plastics Products, Nec (3089)

akta.pro primary industry

Prefilled Syringes & Safety Syringes (HLAHAIAA)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Medical syringe manufacturing
• Hypodermic needle production
• Pre-filled saline syringes
• Sterile medical devices
• Infusion medical devices

Headquarters

HQ city

CAMPLI, Te

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical device manufacturing and sales: Pentaferte generates revenue through the design, manufacturing, and sale of medical devices including syringes (empty and pre-filled), hypodermic needles, blood lancets, and OEM/custom products. The company operates in all world markets and serves hospitals, pharmaceutical companies, home care, veterinary, and industrial sectors. Revenue comes from product sales as a manufacturer and distributor.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Pentaferte Italia designs and manufactures medical devices, primarily syringes and hypodermic needles, at its Campli production facility. Its product portfolio includes empty three-piece syringes (with and without needle), pre-filled saline syringes (PentaFlush, 3-20ml), large capacity syringes (50-100ml), zero-residue syringes (PentaFine R0), silicone-coated hypodermic needles (PentaLance), and blood lancets, plus OEM/custom manufacturing services for medical device clients.

Product overview

PENTAFERTE ITALIA is a medical device manufacturer specializing in syringes and needles for the global market. The product portfolio includes four main product lines: (1) Infusion products for drug administration including large capacity syringes and three-piece syringes; (2) Sampling products for substance extraction including three-piece syringes with/without needle, hypodermic needles, and blood lancets; (3) Pre-filled syringes (PentaFlush brand) for vascular access device flushing; and (4) OEM custom manufacturing services. The company produces empty syringes ranging from 0.5ml to 100ml in transparent or amber versions, available in Luer Lock or Luer Slip configurations, suitable for hospitals, veterinary, pharmaceutical, and industrial applications. Pre-filled syringes contain pre-measured saline solution (3ml, 5ml, 10ml, 20ml) and are sterile, single-use devices. All products are manufactured at the Campli facility using ethylene oxide sterilization and are distributed globally through the parent company Numantec Group.

Differentiator

Problem solved

Functional benefit

Brands

• PentaFlush: Brand of sterile pre-filled saline syringes for flushing vascular access devices, available in 3ml, 5ml, 10ml, and 20ml sizes.
• PentaLance
• PentaFine R0

Products and services

• PentaFlush Pre-Filled Saline Syringes Sterile, single-use pre-filled syringes pre-loaded with saline solution (3ml, 5ml, 10ml, 20ml) for optimal flushing of vascular access devices. Ready-to-use format reduces dosing errors and contamination risk for hospitals, healthcare facilities, and home care providers.
• PentaFine R0 Zero-Residue Syringes Three-piece syringes engineered with minimized dead space (zero residue) to deliver the full dose to diabetic patients. Provides an immediate, non-traumatic injection experience for self-administered subcutaneous therapy.
• Large Capacity Syringes (50/60ml and 100ml) Sterile high-volume syringes in 50ml, 60ml (amber light-resistant for light-sensitive drugs), and 100ml capacities. The 100ml format includes a detachable Luer adapter housed in the plunger for high-volume administration in medical and industrial settings.
• Three-Piece Syringes Without Needle Empty sterile three-piece syringes supplied without needle in Luer Lock or Luer Slip configurations. Suitable for aspiration and administration of various medications in hospitals, pharmaceutical, veterinary, and home care settings.
• Three-Piece Syringes With Needle Three-piece syringes pre-assembled with needle, supplied sterile and ready to use. Designed for medical, pharmaceutical, and veterinary applications requiring integrated needle and syringe configurations.
• PentaLance Hypodermic Needles Sterile silicone-coated hypodermic needles with triple sharpening to ISO 7864 standard, delivering excellent penetration. Available in a wide range of gauges and lengths for hospitals, clinics, pharmaceutical, and industrial users.
• Blood Lancets Sterile single-use blood lancets with an ultra-sharp tip for easy skin penetration and a plastic handle for easy device manipulation. Used by hospitals, clinics, and home care providers for capillary blood sampling.
• OEM (Original Equipment Manufacturing) Services Custom OEM manufacturing services for medical device clients, providing tailored syringe and needle development and production using Pentaferte's injection moulding, clean room assembly, and ethylene oxide sterilization capabilities.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Partnerships

Five partnerships are on record, tiered core and minor.

• Numantec GroupcoreStrategic or Co-development Partner · 1 November 2023Numantec is the new unified brand (New Human Innovation Technology) for the combined Delta Med Group companies. Numantec includes Delta Med (vascular access catheters), Pentaferte (syringes), DBM (pre-filled syringes), AdriaMed (elastomeric pumps), BEL (urodynamic catheters), Securmed (urology, surgery, anesthesia devices), PHS Medical (Port and PICC Port catheters), and Health Line (long catheters for vascular access). The group has 100M+ euros revenue, 6 production plants, and 400+ employees.
• DBMcoreStrategic or Co-development Partner · 1 April 2023In April 2023, Delta Med Group and DBM announced a strategic partnership to strengthen their positioning in the pre-filled syringes market. DBM is a leading manufacturer of pre-filled syringes. The Cadringher family reinvested in the Group, with Roberto Cadringher joining Delta Med's Board of Directors. The combination created a company with approximately 100 million euros in revenue, over 300 employees, and direct presence in Italy and France.
• Delta Med SpacoreStrategic or Co-development Partner · 1 September 2022In September 2022, Pentaferte entered a strategic partnership with Delta Med Group to create a champion in the Italian and European infusion medical device market. Pentaferte became part of the Delta Med Group, with the Romagnoli family and key managers retaining a relevant stake. Gianluca Romagnoli continued in a key leadership role. In November 2023, the combined group rebranded as Numantec.
• Pentaferte FrancecoreChannel Partner/ Reseller/ DistributorPentaferte France is a wholly-owned subsidiary in Villeparisis, France, handling distribution and marketing of Penta and Securmed brand products on the French domestic market. It also distributes exclusive international brands qualifying as high-tech medical devices. Direction: Xavier MESNIL.
• United Nations Global CompactminorOthersPentaferte Italia is a participant of the United Nations Global Compact, the world's largest corporate sustainability initiative. By joining, the company commits to aligning its operations with ten universally accepted principles covering human rights, labor, environment, and anti-corruption.

Scale indicators7 records

Recent moves9 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pentaferte
• LinkedInlinkedin.com/company/pentaferte-italia-s.r.l.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PENTAFERTE ITALIA